Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ukko
AddedFeb 17, 2024
UpdatedJun 18, 2026
Ukko

Ukko

Series B

Biotech firm dedicated to enhancing lives by tackling food allergies and gluten-related disorders.

HQ
Palo Alto, CA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to enhance lives by tackling food allergies and gluten-related disorders, Ukko is a biotech firm leveraging computational protein design to create groundbreaking therapeutic solutions. The company focuses on addressing the significant social, health, and economic impacts of food allergies, which affect millions globally and result in substantial healthcare costs annually.

Ukko has attracted notable investors and industry experts, contributing to its rapid advancements in the biotech sector. The company's innovative approach and commitment to improving public health have led to significant achievements, positioning Ukko as a leader in developing effective treatments for food allergies.

Ukko - Similar Companies

ClostraBio logo

ClostraBio

clostrabio.com

Empire Biotechnologies logo

Empire Biotechnologies

Orthogonal Thinker logo

Orthogonal Thinker

BioHealthonomics logo

BioHealthonomics

Allergenis logo

Allergenis

allergenis.com

Eikon Therapeutics logo

Eikon Therapeutics

eikontx.com

Plasma Nutrition logo

Plasma Nutrition

becomeio.com

Petri Bio logo

Petri Bio

petribio.com

Uplifting Results Labs logo

Uplifting Results Labs

muniqlife.com

Aurion Biotech logo

Aurion Biotech

aurionbiotech.com

Ultivue logo

Ultivue

ultivue.com

Ready Set Food! logo

Ready Set Food!

readysetfood.com

Unity Biotechnology logo

Unity Biotechnology

one.bio logo

one.bio

one.bio

Elo Life Systems logo

Elo Life Systems

Ukko - Quick Facts

Who are Ukko's competitors?

Companies similar to Ukko include ClostraBio, Empire Biotechnologies, Orthogonal Thinker and BioHealthonomics.

When was Ukko founded?

Ukko was founded in 2016.

Where is Ukko's headquarters located?

Ukko's headquarters is located in Palo Alto, CA, US.

When was Ukko's last funding round?

Ukko's most recent funding round was for $40M (USD) in January 2021.

How much has Ukko raised to-date?

As of Jan 27, 2021, Ukko has raised a total of $47.7M (USD).

How many employees does Ukko have?

Ukko has 70 employees as of Feb 4, 2024.

Ukko - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Therapeutics
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 7 more industry codes
NAICS
  • 310000Manufacturing
  • 311000Food Manufacturing
  • 620000Health Care and Social Assistance
SIC
  • 2000Food And Kindred Products
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified